secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akari Therapeutics Plc (AKTX)
CIK:        0001541157
Form:       8-K
Filed at:   2025-12-08T23:59:59+00:00
Accession:  0001493152-25-026533
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Akari Therapeutics furnishes investor presentation for conferences
------------------------------------------------------------------

- Investor presentation furnished as Exhibit 99.1 on December 8, 2025.
- Presentation intended for use at conferences and meetings by company officers.
- No specific financial or pipeline details disclosed in the filing body.
- Filing signed by President and CEO Abizer Gaslightwala.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1541157/000149315225026533/0001493152-25-026533-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1541157/000149315225026533/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-026533

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer